-
Differential adoption of castration-resistant prostate cancer treatment across facilities in a national healthcare system.
18 Feb 2023 06:16 GMT
… largely replaced ketoconazole as oral treatments for castration-resistant prostate cancer (CRPC). … abiraterone, enzalutamide, docetaxel, or ketoconazole between 2010 and 2017. We … identified 4998 men treated with ketoconazole, docetaxel, abiraterone, or …
-
Erleada interactions: Alcohol, medications, and other factors
02 Apr 2024 17:41 GMT
… prescribed for certain types of prostate cancer. Erleada has interactions with … (Lopid)
itraconazole (Sporanox, Tolsura)
ketoconazole
nefazodone
nelfinavir (Viracept)
posaconazole (Noxafil … diagnosis: To learn more about prostate cancer, see our cancer hub. …
-
Characterization of Drug with Good Glass-Forming Ability Loaded Mesoporous Silica Nanoparticles and Its Impact Toward in vitro and in vivo Studies
05 Mar 2024 12:20 GMT
… salicylic acid (SA)/ketoconazole (KCZ) and SA… R. Spectrophotometric study of ketoconazole binding with citrate capped … 44. Van Tyle JH; Ketoconazole. Mechanism of action, spectrum … in patients with metastatic prostate cancer who underwent orchiectomy: a …
-
Janssen to Present New Data in Urothelial, Hematologic and Prostate Cancers at ASCO 2018, Including Best of ASCO Selections
16 May 2018 22:45 GMT
… sensitive prostate cancer (CSPC) will be presented.
Prostate Cancer: … metastatic castration resistant prostate cancer (mCRPC)
Poster … nonmetastatic castration-resistant prostate cancer (nmCRPC)
Poster Discussion … co-administration of ketoconazole, a strong …
-
ZYTIGA(R) (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer
08 Feb 2018 16:45 GMT
… metastatic hormone-sensitive prostate cancer (HSPC) in literature, refers to prostate cancer that still … interaction trial, co-administration of ketoconazole, a strong inhibitor of CYP3A4 …
-
ZYTIGA® (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer
08 Feb 2018 13:51 GMT
… metastatic hormone-sensitive prostate cancer (HSPC) in literature, refers to prostate cancer that still … interaction trial, co-administration of ketoconazole, a strong inhibitor of CYP3A4 …
-
Researchers reveal biomarker for guiding prostate cancer treatment
16 Oct 2017 11:53 GMT
… patient responses to specific prostate cancer therapies.
The studies … variant in two different prostate cancer patient populations, following … more sensitive to ketoconazole."
These discoveries … discovers metabolite of prostate cancer drug more effective …
-
Janssen Submits Supplemental New Drug Application to U.S. FDA for ZYTIGA® (abiraterone acetate) to Treat Men with Earlier Stages of Metastatic Prostate Cancer
14 Sep 2017 21:55 GMT
… prostate cancer growth, at three sources: in the testes, adrenals and the prostate tumor … trial, co-administration of ketoconazole, a strong inhibitor of … 4 Harvard University. Prostate Cancer Knowledge. Androgen-Independent Prostate Cancer. Available at: …
-
Abiraterone Acetate Provided Significant Clinical Benefit in Patients with High-Risk Metastatic Hormone-Naïve Prostate Cancer (mHNPC), Improving Overall Survival and Radiographic Progression-Free Survival
03 Jun 2017 11:58 GMT
… prostate cancer growth, at three sources: in the testes, adrenals and the prostate tumor … interaction trial, co-administration of ketoconazole, a strong inhibitor of CYP3A4 …
-
ASCO 2017: Janssen to Present 19 Abstracts in Prostate Cancer and a Spectrum of Blood Cancers; Includes Data on Abiraterone Acetate, Daratumumab and Ibrutinib
17 May 2017 21:47 GMT
… of metastatic castration-resistant prostate cancer: the prostate cancer registry
Poster Session
Monday … prostate cancer growth – at three sources: in the testes, adrenals and the prostate tumor … trial, co-administration of ketoconazole, a strong inhibitor of …